SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-23-000018
Filing Date
2023-01-05
Accepted
2023-01-05 18:58:09
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167296307107599.html 4  
1 FORM 4 wf-form4_167296307107599.xml 4 4146
  Complete submission text file 0001626199-23-000018.txt   5691
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 23513030